Joo et al. found that both CD133-positive and -negative cells obtained from GBM patients could produce GBM tumor chunks in the brains of immunodeficient mice, while brain tumor chunks containing CD133-negative cells showed higher proliferative and angiogenic ability than brain tumor chunks generated from CD133-positive cells [95]. This evidence concerns the gene PROM1 and neoplasm.